Core Insights - JAKKS Pacific, Inc. reported Q4 and full-year 2025 financial results, showing a bottom-line growth despite challenges from tariff policies [1][4] - The company declared a quarterly cash dividend of $0.25 per share, marking its first full year as a cash dividend payer [7] Q4 2025 Financial Performance - Q4 net sales were $127.1 million, a decrease of 2.8% year-over-year, with Toys/Consumer Products division net sales at $118.0 million, down 0.2% from the previous year [5][9] - Gross margins improved to 31.0%, up 380 basis points compared to Q4 2024, with gross profit increasing by 11% to $39.4 million [9] - Operating loss for Q4 was $8.6 million, an improvement from a loss of $14.7 million in Q4 2024 [9] Full-Year 2025 Financial Performance - Full-year net sales decreased by 17% to $570.7 million, with Toys/Consumer Products net sales down 19% to $461.9 million [9][27] - Gross margin for the full year was 32.4%, compared to 30.8% in 2024, with gross profit declining by 13% to $185.1 million [9] - Net income attributable to common stockholders was $9.9 million, down from $35.3 million in 2024 [9] Geographic Sales Performance - U.S. sales fell by 8% in Q4 and 24% for the full year, while international sales increased by 10% in Q4 and 6% for the full year, primarily driven by Europe [6][27] - In Q4, sales in Europe were stable, while Latin America saw a significant increase of 106.2% [27] Inventory and Cash Flow - Inventory as of December 31, 2025, was $59.8 million, up from $52.8 million in 2024, attributed to an expanded warehouse network in the EU [6] - Cash returned to shareholders totaled $11.2 million, with end-of-year cash and cash equivalents at $54.1 million, down from $70.1 million in 2024 [9]

Core Insights - iRhythm Holdings, Inc. reported strong financial results for Q4 and full year 2025, marking a transformational year with significant revenue growth and positive net income for the first time in its history [4][10]. Financial Highlights Fourth Quarter 2025 - Revenue increased by 27.1% to $208.9 million compared to $164.3 million in Q4 2024, driven by higher demand for Zio Services [5][8]. - Gross profit rose to $148.1 million, up from $115.1 million in Q4 2024, with a gross margin of 70.9%, an improvement from 70.0% [6][8]. - Net income for Q4 2025 was $5.6 million, a significant improvement from a net loss of $1.3 million in Q4 2024 [9][8]. - Adjusted EBITDA was $34.3 million, with an adjusted EBITDA margin of 16.4%, reflecting a $15.0 million increase compared to Q4 2024 [8]. Full Year 2025 - Total revenue for 2025 reached $747.1 million, a 26.2% increase from $591.8 million in 2024 [10][11]. - Gross profit for the year was $527.3 million, up from $407.5 million in 2024, with a gross margin of 70.6%, improving from 68.9% [11]. - The net loss for 2025 was $44.6 million, a $68.7 million improvement compared to a net loss of $113.3 million in 2024 [12][10]. - Free cash flow for 2025 was $34.5 million, marking the first year of positive free cash flow in the company's history [8]. Operational Highlights - The company emphasized the growing demand for Zio across various healthcare sectors, highlighting its ability to provide proactive, data-driven arrhythmia detection [4]. - iRhythm plans to scale its platform globally, advance its product roadmap, and enhance its predictive AI capabilities while maintaining financial discipline [4]. 2026 Guidance - For 2026, iRhythm expects revenue between $870 million and $880 million, with an adjusted EBITDA margin of 11.5% to 12.5%, indicating continued growth and operational efficiency [13].

Company to Host Quarterly Conference Call at 5:00 P.M. ET on February 19, 2026The information in this press release should be read in conjunction with an earnings presentation that is available on the Company's website at investors.amcoastal.com/events-and-presentations. ST. PETERSBURG, Fla., Feb. 19, 2026 (GLOBE NEWSWIRE) -- February 19, 2026: American Coastal Insurance Corporation (Nasdaq: ACIC) ("ACIC" or the "Company"), a property and casualty insurance holding company, today reported its financial res ...

October 2025 acquisition cohort tracking as best-performing October in Company history; acquisitions increased 46% quarter-over-quarter while inventory days in possession reduced 23%SAN FRANCISCO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Opendoor Technologies Inc. (Nasdaq: OPEN), a leading e-commerce platform for residential real estate transactions, today reported financial results for its fourth quarter and year ended December 31, 2025. “Last quarter, we outlined a four-step plan to transform Opendoor: reach bre ...

HORSHAM, Pa., Feb. 19, 2026 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that a Form 25 has been filed today with the SEC to deregister its common stock under Section 12(b) of the Securities Exchange Act of 1934, as amended (“Exchange Act”), and confirms that trading of the Company’s common stock has bee ...

IRVINE, Calif., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that management will present at TD Cowen’s 46th Annual Health Care Conference on Wednesday, March 4, 2026 at 10:30 am Eastern Time (7:30 am Pacific Time). A live audio webcast of the presentation will be available on the Company’s website in the “Investors—Events & Presentations” section at https://investors.betabionics.com, an ...

SEATTLE, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced the company will be participating in the TD Cowen 46th Annual Health Care Conference. Nautilus’ management is scheduled to participate in a fireside chat on Monday, March 2, 2026, at 10:30 a.m. Eastern Time. Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company ...

CHICAGO, Feb. 19, 2026 (GLOBE NEWSWIRE) -- Century Aluminum Company (NASDAQ: CENX) today announced its fourth quarter and full year 2025 results. Fourth Quarter 2025 Highlights Net sales of $633.7 millionReported net income attributable to Century stockholders of $1.8 million, or $0.02 per diluted share; Adjusted net income attributable to Century stockholders of $128.2 million1, or $1.25 per share; Adjusted EBITDA attributable to Century stockholders of $170.6 million1Ending cash and cash equivalents of $1 ...

NEEDHAM, Mass., Feb. 19, 2026 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today announced the launch of an underwritten public offering of $100 million of its common stock. Candel also intends to grant the underwriters a 30-day option to purchase up to an additional $15 million in shares of its common stock on the same terms and condi ...

Core Insights - Casella Waste Systems, Inc. reported strong financial results for Q4 2025, achieving double-digit growth in revenue, Adjusted EBITDA, and Adjusted Free Cash Flow for the fifth consecutive year, driven by successful acquisitions and operational strategies [3][4][6]. Financial Performance - Q4 2025 revenues reached $469.1 million, an increase of $41.6 million or 9.7% compared to Q4 2024, primarily due to acquisitions, price growth in collection and disposal, and strong performance in National Accounts [4][6]. - For the fiscal year 2025, total revenues were $1.837 billion, up $279.6 million or 18.0% from fiscal year 2024 [6][9]. - Solid waste pricing increased by 4.9% in fiscal year 2025, with collection prices growing by 5.0% and disposal prices by 4.9% [6]. - Operating income for Q4 2025 was $11.9 million, down $6.6 million or 35.9% from Q4 2024, attributed to higher depreciation and amortization expenses [5][9]. - Net loss for Q4 2025 was $(2.5) million, a decrease of $(7.4) million compared to a net income of $4.9 million in Q4 2024 [7][10]. - Adjusted EBITDA for Q4 2025 was $107.0 million, an increase of $12.0 million or 12.7% from Q4 2024 [7][12]. - Fiscal year 2025 Adjusted Net Income was $80.6 million, up $1.8 million or 2.3% from fiscal year 2024 [11][12]. Acquisition Strategy - In 2025, the company acquired nine businesses, contributing approximately $145 million in annualized revenue, with a robust acquisition pipeline for 2026 [3][6]. - Over the past five years, Casella has acquired more than $800 million in annualized revenue through tuck-in acquisitions and new market entries [3][6]. Future Outlook - For fiscal year 2026, the company provided guidance estimating revenues between $1.970 billion and $1.990 billion, net income between $16 million and $22 million, and Adjusted EBITDA between $455 million and $465 million [14][16].